 NEW YORK LONDON PARIS--BUSINESS WIRE-- CTAsubmission--Regulatory News: Aptorum Group Limited Nasdaq: APM, Euronext Paris: APM Aptorum Group or Aptorum, a biopharmaceutical company focused on novel technologies for the treatment of a variety of medical conditions including infectious diseases, announced that the company, through its wholly owned subsidiary Aptorum International Limited, has submitted a Clinical Trial Application CTA with the Public Health Agency of Canada Health Canada to cond 